Yeter, Duygu YalinbasEroglu, SerapSariakcali, BarisBozali, ErmanOzec, Ayse VuralErdogan, Haydar2024-10-262024-10-2620220927-39481744-5078https://doi.org/10.1080/09273948.2020.1849739https://hdl.handle.net/20.500.12418/28861Purpose: To determine the association of monocyte-to-high-density lipoprotein ratio (MHR) and neutrophil-to-lymphocyte ratio (NLR) with diabetic macular edema (DME) and early anti-VEGF treatment response. Material methods: This was a retrospective and cross-sectional study conducted with 143 patients with diabetes mellitus (53 diabetic retinopathy with DME, 38 diabetic retinopathy without DME, and 52 without diabetic retinopathy). Results: 13.9 was the best cutoff value to predict DME for MHR, and 2 was for NLR (59% and 75% sensitivity and 81% and 59% specificity, respectively). Logistic regression analysis showed that NLR >= 2 and MHR >= 13.9 were significantly associated with DME prediction. However, neither NLR >= 2 nor MHR >= 13.9 was associated with central retinal thickness(CRT) or best corrected visual acuity(BCVA) outcomes after anti-VEGF treatment. On the other hand, increased NLR was associated with inferior CRT outcomes. Conclusion: MHR and NLR were simple and cost-effective biomarkers to predict DME. Moreover, higher NLR may contribute to poor CRT outcomes.en10.1080/09273948.2020.1849739info:eu-repo/semantics/closedAccessDiabetesmacular edemaretinopathyinflammationmonocytehigh-density lipoproteinArticle304906901335963982-s2.0-85101043463Q1WOS:000619052100001Q2